Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516216 · ClinicalTrials.gov registry record · Phase 2
Study of Vitamin D in Untreated Metastatic Colorectal Cancer
A Phase 2 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 139
- Enrollment target
NCT01516216 is a Phase 2 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 139 participants.
The verdict
NCT01516216, a Phase 2 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 139 participants
- Enrollment target
Study Summary
This is a prospective, randomized, double-blind phase II trial to evaluate the efficacy and safety of two doses of vitamin D supplementation in combination with standard chemotherapy in participants with previously-untreated metastatic colorectal adenocarcinoma.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DRUG FOLFOX + bevacizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2012-04-13 |
| Est. Completion | 2019-11-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01516216
The ClinicalTrials.gov registry entry for NCT01516216 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D is the first listed.
NCT01516216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01516216 about?
NCT01516216 is a clinical study titled "Study of Vitamin D in Untreated Metastatic Colorectal Cancer". This is a prospective, randomized, double-blind phase II trial to evaluate the efficacy and safety of two doses of vitamin D supplementation in combination with standard chemotherapy in participants with previously-untreated metastatic colorectal adenocarcinoma.
What is the current status of trial NCT01516216?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 139 participants. The study started on 2012-04-13. Estimated completion is 2019-11-09.
What interventions are being tested in trial NCT01516216?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), FOLFOX + bevacizumab (DRUG).
Who is sponsoring clinical trial NCT01516216?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.